BNY Mellon Global Real Return Fund - Class A
DRRAX
NASDAQ
| Weiss Ratings | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Reward Grade | D+ | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Company Info | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | BNY Mellon | |||
| Manager/Tenure (Years) | Aron Pataki (9), Ella Hoxha (0), Nick Pope (0) | |||
| Website | http://www.bnymellonim.com/us | |||
| Fund Information | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | BNY Mellon Global Real Return Fund - Class A | |||
| Category | Tactical Allocation | |||
| Sub-Category | Flexible Allocation | |||
| Prospectus Objective | Growth and Income | |||
| Inception Date | May 12, 2010 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 1,000.00 | |||
| Minimum Subsequent Investment | 100.00 | |||
| Front End Fee | 0.06 | |||
| Back End Fee | -- | |||
| Dividends and Shares | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 4.82% | |||
| Dividend | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 1.82% | |||
| Asset Allocation | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 4.59% | |||
| Stock | 45.79% | |||
| U.S. Stock | 27.68% | |||
| Non-U.S. Stock | 18.11% | |||
| Bond | 40.12% | |||
| U.S. Bond | 11.40% | |||
| Non-U.S. Bond | 28.72% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 9.50% | |||
| Price History | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.73% | |||
| 30-Day Total Return | 2.36% | |||
| 60-Day Total Return | 2.93% | |||
| 90-Day Total Return | 5.92% | |||
| Year to Date Total Return | 7.79% | |||
| 1-Year Total Return | 8.18% | |||
| 2-Year Total Return | 21.30% | |||
| 3-Year Total Return | 19.13% | |||
| 5-Year Total Return | 22.58% | |||
| Price | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $16.46 | |||
| 1-Month Low NAV | $16.02 | |||
| 1-Month High NAV | $16.46 | |||
| 52-Week Low NAV | $14.23 | |||
| 52-Week Low NAV (Date) | Apr 07, 2025 | |||
| 52-Week High NAV | $16.56 | |||
| 52-Week High Price (Date) | Dec 06, 2024 | |||
| Beta / Standard Deviation | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.90 | |||
| Standard Deviation | 6.38 | |||
| Balance Sheet | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 848.58M | |||
| Operating Ratios | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 1.18% | |||
| Turnover Ratio | 77.47% | |||
| Performance | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 6.23% | |||
| Last Bear Market Total Return | -2.90% | |||